Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors
Clinical presentation, biochemical workup, and therapeutical response to diazoxide and somatostatin analogues are consistent with previous reports of HADH mutations. The overexpression of glucagon-like peptide 1 receptors in this context warrants further research.
Authors
- Stéphanie Meier (ORCID: https://orcid.org/0000-0002-8106-4203)
- Julie De Geyter (ORCID: https://orcid.org/0000-0002-8721-5383)
- Emanuel Christ (ORCID: https://orcid.org/0000-0002-5604-4606)
- Damian Wild (ORCID: https://orcid.org/0000-0002-8135-5350)
- Jean‐Marc Nuoffer (ORCID: https://orcid.org/0000-0003-3650-6153)
- Gabor Szinnai (ORCID: https://orcid.org/0000-0003-0559-2597)
- Isabel Filges (ORCID: https://orcid.org/0000-0002-2149-6354)
- Kwadwo Antwi
- Urs Zumsteg
- Andrea Widmer
Institutions
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- Hospital Base (CL)
- University Children’s Hospital Bern (CH)
- University Children’s Hospital Basel (CH)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1210/clinem/dgaf423
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00